QUANTGENE

About QUANTGENE

Quantgene operates in the precision genomics and medical intelligence market, focusing on early cancer detection and improved clinical outcomes. The company serves hospitals, physicians, and patients by providing turnkey solutions that integrate genomics, imaging, and medical intelligence. Quantgene's core product, Quantgene Qx, allows for comprehensive cancer screening through a single system, enabling the detection of cancer signals at much earlier stages. The business model revolves around offering complete value chains, including patient activation, fully managed laboratories, and revenue recognition for healthcare providers. Quantgene generates revenue through partnerships, such as its collaboration with Getlabs, which expands access to at-home diagnostic collections. The company aims to make genomics accessible and profitable for healthcare institutions while elevating the quality of care.